Which has grown faster, RLAY or VCYT?

Over the past five years, VCYT grew revenue faster — RLAY at a -34.29% CAGR versus VCYT at 28.98%.

Is RLAY or VCYT more profitable?

VCYT runs the higher net margin — RLAY at -2763.64% versus VCYT at 20.37%.

How have RLAY and VCYT total returns compared?

Over the past 5 years, RLAY delivered -7.92% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.

Relay Therapeutics, Inc. (RLAY) vs Veracyte, Inc. (VCYT)

A side-by-side comparison of Relay Therapeutics, Inc. and Veracyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

RLAY

Relay Therapeutics, Inc.

$4.03B

$18.38HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

VCYT

Veracyte, Inc.

$3.52B

$44.18HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT

Total return — RLAY vs VCYT

growth of $100 · dividends reinvested · last 6y

RLAY -44.7% (-9.4%/yr)VCYT +56.8% (+7.8%/yr)VCYT compounded faster over this window

RLAY VCYT

RLAY vs VCYT: by the numbers

•RLAY is the larger company ($4.03B vs $3.52B market cap).
•VCYT is profitable (20.37% net margin) while RLAY runs a net loss (-2763.64%).
•VCYT grew revenue faster over the past five years (28.98% vs -34.29% CAGR).

Metrics side by side

Valuation

Metric	RLAY	VCYT
P/E ratio	N/A	31.55
Forward P/E	N/A	23.08
P/S ratio	389.21	6.27
P/B ratio	4.53	2.54
EV / EBITDA	N/A	28.02
FCF yield	N/A	4.69%

Profitability

Metric	RLAY	VCYT
Gross margin	76.83%	72.09%
Operating margin	-1971.59%	17.03%
Net margin	-2763.64%	20.37%
ROE	-32.14%	8.25%
ROIC	-33.87%	6.72%

Growth (annualized)

Metric	RLAY	VCYT
Revenue CAGR (5Y)	-34.29%	28.98%
Total return CAGR (5Y)	-7.92%	1.45%

Frequently asked

Which has grown faster, RLAY or VCYT?: Over the past five years, VCYT grew revenue faster — RLAY at a -34.29% CAGR versus VCYT at 28.98%.
Is RLAY or VCYT more profitable?: VCYT runs the higher net margin — RLAY at -2763.64% versus VCYT at 20.37%.
How have RLAY and VCYT total returns compared?: Over the past 5 years, RLAY delivered -7.92% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.

Go deeper

Full RLAY analysis Full VCYT analysis Interactive comparison tool

Dig into the metrics

Veracyte P/E ratio Relay Therapeutics ROE Veracyte ROE Relay Therapeutics operating margin Veracyte operating margin Relay Therapeutics revenue growth Veracyte revenue growth Relay Therapeutics free cash flow Veracyte free cash flow

Relay Therapeutics & Veracyte appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.